Omnicell reported a 17% increase in GAAP revenues for the fourth quarter of 2019, reaching $248.3 million, and a GAAP net income of $22.1 million, or $0.51 per diluted share.
GAAP revenues for the fourth quarter of 2019 were $248.3 million, up 17% from the fourth quarter of 2018.
Fourth quarter 2019 GAAP net income was $22.1 million, or $0.51 per diluted share, compared to $14.8 million, or $0.36 per diluted share, for the fourth quarter of 2018.
Non-GAAP net income for the fourth quarter of 2019 was $33.5 million, or $0.77 per diluted share, compared to $29.1 million, or $0.70 per diluted share, for the fourth quarter of 2018.
Total product backlog for the year ended December 31, 2019, was $588 million, a 23% increase year over year.
For the first quarter of 2020, the Company expects non-GAAP total revenues to be between $221 million and $227 million and expects non-GAAP earnings to be between $0.52 and $0.57 per share.
Analyze how earnings announcements historically affect stock price performance